Drug
Dexlansoprazole clinical trials
Also written Dexilant, Kapidex, TAK-390MR and TAK-390.
- studies test it
- 48
- open now
- 0
- in phase 3
- 14
- first study started
- 2005
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
47 studies that test it; most in 2017 (7)
| Year | Studies |
|---|---|
| 2005 | 4 |
| 2006 | 5 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 7 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 14
- Phase 2
- 7
- Phase 3
- 14
- Phase 4
- 9
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 28 · Other 20
Takeda (27) · First Affiliated Hospital of Zhejiang University (2) · Mayo Clinic (2) · Ayman Magd Eldin Mohammad Sadek (1) · University of Karachi (1) · Northwestern University (1) · Universiti Sains Malaysia (1) · Chang Gung Memorial Hospital (1)
Often tested with
Tested in the same studies.
Esomeprazole (2) · Omeprazole (2) · Lansoprazole (2) · Vonoprazan (1) · Clopidogrel (1)
Studies
Open first, then newest update. How each study uses Dexlansoprazole is read from its arms, and is right about nine times in ten.
Testing it · 48
- A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldCompletedPhase 2TakedaNCT02616302Written as Dexlansoprazole
- A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years OldTerminatedPhase 2TakedaNCT02615184Written as Dexlansoprazole
- Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux DiseaseCompletedPhase 4Ayman Magd Eldin Mohammad SadekNCT06778395Written as Dexlansoprazole 60 mg
- Effect of Dexlansoprazole on Bone HomeostasisCompletedPhase 1TakedaNCT01216293Written as Dexlansoprazole
- Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.CompletedPhase 1University of KarachiNCT04877834Written as Dexlansoprazole
- Effectiveness of Physiologic Testing in PPI Non-RespondersCompletedEarly Phase 1Northwestern UniversityNCT03202537Written as dexlansoprazole
- Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsWithdrawnPhase 1TakedaNCT02442752Written as Dexlansoprazole
- The Effects of Dexlansoprazole for the Treatment of Throat-Related RefluxTerminatedNot applicableIndiana UniversityNCT01317472Written as dexlansoprazole
- The Evaluation of Effectiveness Between Empirical and Guided Therapy for Unexplained Non-Cardiac Chest PainCompletedPhase 2/3Universiti Sains MalaysiaNCT03319121Written as Empirical therapy group
- Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese PatientsCompletedPhase 3TakedaNCT02873689Written as Dexlansoprazole
- Dexlansoprazole MR-Based Concomitant Quadruple TherapyCompletedNot applicableChang Gung Memorial HospitalNCT03829150Written as Dexlan
- A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese ParticipantsCompletedPhase 1TakedaNCT03316976Written as Dexlansoprazole
- Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive EsophagitisTerminatedPhase 3TakedaNCT02873702Written as Dexlansoprazole
- Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter PyloriCompletedPhase 4Ramathibodi HospitalNCT03087162Written as Dexlansoprazole 60 mg once daily
- Dexlansoprazole in Asian Participants With Gastroesophageal Reflux DiseaseCompletedPhase 4TakedaNCT02351960Written as Dexlansoprazole
- An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of RamadanCompletedPhase 4American University of Beirut Medical CenterNCT03079050Written as Dexlansoprazole 60 MG
- Evaluating Treatment Response in Laryngo-Pharyngeal RefluxWithdrawnNot applicableUniversity of WashingtonNCT01328392Written as Dexlansoprazole
- Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationTerminatedPhase 2TakedaNCT02162758Written as Dexlansoprazole
- Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and BCompletedPhase 4Kaohsiung Medical University Chung-Ho Memorial HospitalNCT03128736Written as Dexlansoprazole group
- A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）Status unknownPhase 1First Affiliated Hospital of Zhejiang UniversityNCT03120273Written as Dexlansoprazole Injection
See all 48 studies that test Dexlansoprazole →
As the comparator · 1 — what is tested is compared with Dexlansoprazole
Codes
What other systems call Dexlansoprazole · ClinicalTrials.gg INT008977
- MeSH (NLM) D064748DexlansoprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) UYE4T5I70XDEXLANSOPRAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 816346Confirmed FDA, Wikidata
- Wikidata Q5268339dexlansoprazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73192DexlansoprazoleOne source FDA
- DrugBank DB05351One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D064748 | Dexlansoprazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | UYE4T5I70X | DEXLANSOPRAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 816346 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5268339 | dexlansoprazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73192 | Dexlansoprazole | One source FDA |
| DrugBank | DB05351 | — | One source Wikidata |
Also registered as dexlansoprazole sesquihydrate (UNII HS2S9VK3NH).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.